Pharmacology and toxicology of sensitizers: Mechanism studies

International Journal of Radiation Oncology, Biology, Physics

Volumn 10, Issue 8, 1984, Pages 1293-1300

  Rauth, A M ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Mechanism of action; Metronidazole; Misonidazole; Nitroimidazoles; Reductive metabolism

Indexed keywords

METRONIDAZOLE; MISONIDAZOLE; NITROIMIDAZOLE; NITROIMIDAZOLE DERIVATIVE; RADIOSENSITIZING AGENT;

DRUG EFFICACY; DRUG TOXICITY; INTOXICATION; NONHUMAN; PHARMACOLOGY; RADIOSENSITIZATION; REVIEW;

ANIMAL; CARCINOGENS; HUMAN; METRONIDAZOLE; MISONIDAZOLE; MUTAGENS; NITROIMIDAZOLES; OXIDATION-REDUCTION; RADIATION-SENSITIZING AGENTS; SUPPORT, NON-U.S. GOV'T;

EID: 0021231567     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(84)90335-3     Document Type: Article

References (55)

1. Metronidazole (“flagyl”). A radiosensitizer of hypoxic cells
2. Host and hypoxic cell toxicity studies with the terminal reduction product of misonidazole
3. Clinical perspectives for the use of new hypoxic cell sensitizers
4. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles
5. 3H mice
6. Screening for the mutagenicity of nitre-group containing hypoxic cell radiosensitizers using Salmonella typhimarium strains TA 100 and TA98
7. Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase
8. Evaluation of nitroheterocyclic radiosensitizers using spheroids
9. Editorial Metronidazole-Unanswered questions
10. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs
11. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine
12. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole
13. Beyond radiosensitization: The future of hypoxic-cell sensitizers
14. 14C-misonidazole
15. Metronidazole: Proven benefits and potential risks
16. The development of 5-nitroimidazoles for the treatment and prophylaxis of anerobic bacterial infections
17. Reactions of nitroimidazoles. Nucleophilic substitution of the nitre-group
18. Comparison of the incidence of oncogenic transformation produced by x-rays, misonidazole and chemotherapy agents
19. Chemical and enzymatic nitroreduction: Free radical and diamagnetic products of nitroimidazoles
20. Synthesis and properties of reduced derivatives of misonidazole
21. Reduction of misonidazole and its derivatives by xanthine oxidase
22. Effect of excision repair on the mutagenesis of misonidazole
23. The hypoxic tumor cell: A target for selective cancer chemotherapy
24. Studies on the action of nitroimidazole drugs, the products of nitroimidazole reduction
25. Interaction of metronidazole with nucleic acids in vitro
26. Antitrichomonal action, mutagenicity, and reduction of metronidazole and other nitroimidazoles
27. The molecular mechanism of antitumor action of the mitomycins
28. Free-radical intermediates in the metabolism of toxic chemicals
29. Nitrofurazonereducing enzymes in E. coli and their role in drug activation in vivo
30. 2-Hydroxylaminoimidazoles-Unstable intermediates in the reduction of 2-nitroimidazoles
31. Enhancement of chemotherapy agents
32. Effects of reduction products of misonidazole on Chinese hamster ovary cells
33. Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells
34. Correlation between the half-wave reduction potentials of nitroheterocyclics and their mutagenicity in Chinese hamster V-79 spheroids
35. Clinical trials of hypoxic cell sensitizers
36. Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases-Glyoxal formation from misonidazole
37. Possible role of N - 1 substitution on the mutagenicity of 2-nitroimidazoles (Abstr.)
38. The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system
39. Hypoxic radiosensitizers: Prospects for effective compounds with fewer toxic side-effects
40. Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in non inbred Sas:MRC(WI) BR rats
41. Metabolism of nitroimidazoles
42. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver-A model system
43. Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers
44. Synthesis of 1-(2-hydroxy ethyl)-2-methyl-5-aminoimidazole: A ring-intact reduction product of metronidazole
45. Glutathione conjugates of misonidazole
46. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazoyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo
47. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole
48. Cellular and chemical reduction products of misonidazole
49. Modification of guanine derivatives by reduced 2-nitroimidazoles
50. The use of nitroaromatic compounds as hypoxic cell sensitizers
51. The radiation reduction of misonidazole
52. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation
53. Role of suffhydryl compounds in the bactericidal effect of metronidazole
54. Reduction of nitroheterocyclic compounds by mammalian tissues in vivo